Your browser doesn't support javascript.
loading
An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey.
Çaglayan, Derya; Süner, Ahmet F; Siyve, Neslisah; Güzel, Irmak; Irmak, Çaglar; Isik, Elif; Appak, Özgür; Çelik, Muammer; Öztürk, Gamze; Alp Çavus, Sema; Ergör, Gül; Sayiner, Arzu; Ergör, Alp; Demiral, Yücel; Kiliç, Bülent.
Afiliação
  • Çaglayan D; Department of Public Health, Division of Epidemiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Süner AF; Department of Public Health, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Siyve N; Department of Public Health, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Güzel I; Department of Medical Microbiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Irmak Ç; Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Isik E; Department of Public Health, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Appak Ö; Department of Medical Microbiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Çelik M; Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Öztürk G; Department of Medical Microbiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Alp Çavus S; Department of Medical Microbiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Ergör G; Department of Public Health, Division of Epidemiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Sayiner A; Department of Medical Microbiology, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Ergör A; Department of Public Health, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Demiral Y; Department of Public Health, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
  • Kiliç B; Department of Public Health, School of Medicine, Dokuz Eylül University, Izmir, Turkey.
J Med Virol ; 94(5): 2212-2221, 2022 05.
Article em En | MEDLINE | ID: mdl-35075655
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Med Virol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Med Virol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia País de publicação: Estados Unidos